Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
Clinical trial NCT01766817 · COMPLETED
Trial details
- NCT number
- NCT01766817
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-31
- Primary completion
- 2016-02-29
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.